Evidence map›Paper›PMID 34644576›Full record

ArticleCell reports2021

USP7 and VCP

André Franz, Pablo Valledor, Patricia Ubieto-Capella, Domenic Pilger, Antonio Galarreta, Vanesa Lafarga, Alejandro Fernández-Llorente, Guillermo de la Vega-Barranco, Fabian den Brave, Thorsten Hoppe and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. The SUMO Pathway.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  7. Multifaceted roles of SUMO in DNA metabolism.Nucleus (Austin, Tex.) · 2024
    Review
  8. Article
  9. Article
  10. SUMO and the DNA damage response.Biochemical Society transactions · 2024
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. SUMO enhances unfolding of SUMO-polyubiquitin-modified substrates by the Ufd1/Npl4/Cdc48 complex.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  17. Targeting DNA-Protein CrosslinksFrontiers in molecular biosciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 4 countries.

André FranzInstitute for Genetics and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany.
Pablo ValledorGenomic Instability Group, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Patricia Ubieto-CapellaGenomic Instability Group, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Domenic PilgerThe Wellcome Trust and Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge CB2 1QN, UK.
Antonio GalarretaGenomic Instability Group, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Vanesa LafargaGenomic Instability Group, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Alejandro Fernández-LlorenteChromatin, Cancer and the Ubiquitin System lab, Centre for Molecular Biology Severo Ochoa (CBMSO, CSIC-UAM), Department of Genome Dynamics and Function, Madrid 28049, Spain.
Guillermo de la Vega-BarrancoChromatin, Cancer and the Ubiquitin System lab, Centre for Molecular Biology Severo Ochoa (CBMSO, CSIC-UAM), Department of Genome Dynamics and Function, Madrid 28049, Spain.
Fabian den BraveInstitute of Biochemistry and Molecular Biology, University of Bonn, 53115 Bonn, Germany.
Thorsten HoppeInstitute for Genetics and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. Electronic address: thorsten.hoppe@uni-koeln.de.
Oscar Fernandez-CapetilloGenomic Instability Group, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain; Science for Life Laboratory, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 171 21 Stockholm, Sweden. Electronic address: ofernandez@cnio.es.
Emilio LeconaChromatin, Cancer and the Ubiquitin System lab, Centre for Molecular Biology Severo Ochoa (CBMSO, CSIC-UAM), Department of Genome Dynamics and Function, Madrid 28049, Spain. Electronic address: elecona@cbm.csic.es.
Spanish National Cancer Research Centre · ESCentro de Biología Molecular Severo Ochoa · ESUniversity of Cologne · DEConsejo Superior de Investigaciones Científicas · ESScience for Life Laboratory · SEUniversity of Bonn · DEUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The AAA

Indexed as

DNA ReplicationUbiquitinationAdaptor Proteins, Signal TransducingAnimalsAnimals, Genetically ModifiedApoptosis Regulatory ProteinsCaenorhabditis elegansCaenorhabditis elegans ProteinsCarrier ProteinsChromatinEndopeptidasesEvolution, MolecularHCT116 CellsHeLa CellsHumansMCF-7 CellsAdaptor Proteins, Signal TransducingApoptosis Regulatory ProteinsCaenorhabditis elegans ProteinsCarrier Proteinscdc-48.1 protein, C elegansChromatinEndopeptidasesFAF1 protein, humanMATH-33 protein, C elegansUbiquitin-Specific Peptidase 7UBXN-3 protein, C elegansUSP7 protein, humanValosin Containing ProteinVCP protein, humanCDC-48DNA replicationDUBFAF1MATH-33SUMOubiquitinUBXN-3USP7VCP

Identifiers

PMID34644576
PMCPMC8527565
OpenAlexW3206348749

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.